Does PONATINIB Cause Myelosuppression? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Myelosuppression have been filed in association with PONATINIB (Iclusig). This represents 0.4% of all adverse event reports for PONATINIB.
43
Reports of Myelosuppression with PONATINIB
0.4%
of all PONATINIB reports
7
Deaths
12
Hospitalizations
How Dangerous Is Myelosuppression From PONATINIB?
Of the 43 reports, 7 (16.3%) resulted in death, 12 (27.9%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for PONATINIB.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which PONATINIB Alternatives Have Lower Myelosuppression Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE